BioNTech SE
BNTX
NASDAQ. Currency in USD
168.56 -6.69 ( -3.82% )
Market Cap.
40.91B
Beta (5Y monthly)
0.16
Price/Earnings
3.88
EPS (TTM)
44.26
Forward Dividend
2.11 (1.13%)
Ex-Dividend Date
Jun 03, 2022
Volume
923,885
1y Target Est.
213.44
Day's Range
52 Week's Range
Historical Summary
Performance
1 Month
1.30%
YTD
-34.62%
1Y
-41.33%
2Y
61.70%
27.18% ann.
3Y
474.51%
79.08% ann.
EPS growth
1Y
27.55%
2Y
2,313.00%
391.78% ann.
Share Buybacks
3 Months
-0.00%
6 Months
0.20%
1Y
-6.89%
2Y
-8.61%
3Y
-12.97%
About BioNTech SE
Sector
Healthcare
Industry
Biotechnology
Website
https://www.biontech.de
Exchange
NASDAQ (XNAS)
Shares Outstanding
246.81M
Employees
4000
Address
An der Goldgrube 12, Mainz, Germany, 55131
Latest news

Moderna's (MRNA) BA.1 Omicron Booster Gets CHMP Nod for Kids
The CHMP recommends authorizing Moderna's (MRNA) bivalent COVID-19 booster vaccine, targeting the Omicron BA.1 subvariant,...
By Zacks Investment Research - 6 weeks ago

FDA Delays Decision on AstraZeneca (AZN), Merck's Lynparza sNDA
The FDA extends the review period of AstraZeneca (AZN)/Merck's filing seeking label expansion for Lynparza's...
By Zacks Investment Research - 7 weeks ago

Icosavax (ICVX) Up 112% on Upbeat Data From RSV Jab Study
Data from an early-stage study showed that Icosavax's (ICVX) investigational RSV vaccine exhibited sustained immunologic...
By Zacks Investment Research - 7 weeks ago
BioNTech upgraded to buy on high hopes for combined flu/COVID vaccine and oncology pipeline
Bank of America turned bullish on German biotech BioNTech on Thursday
By MarketWatch - 7 weeks ago

BioNTech Stock Gets Upgrade, Analyst Sees Multiple Upside Opportunities
BofA Securities has upgraded BioNTech SE (NASDAQ: BNTX) and maintains a $239 price target.
The...
By Benzinga - 7 weeks ago

Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022
Upgrades
B of A Securities upgraded the previous rating for Radian Group Inc (NYSE:RDN) from...
By Benzinga - 7 weeks ago

Wave Life Sciences (WVE) Up 26% on Collaboration With GSK
Wave Lifesciences (WVE) signs a four-year research collaboration with GSK to advance discovery and development...
By Zacks Investment Research - 7 weeks ago

Eli Lilly (LLY) 2023 Guidance Falls Short, Stock Declines
Eli Lilly's (LLY) 2023 EPS guidance falls short of the Zacks Consensus Estimates and our...
By Zacks Investment Research - 7 weeks ago